We are thrilled about our new partnership with AC Immune and what we can achieve together for the Alzheimer's community.
We are excited to share that we have entered into an exclusive option and license agreement with AC Immune for an active immunotherapy targeting amyloid beta for the treatment of Alzheimer’s disease. Read more here: https://lnkd.in/eJiMMjkb
In this real-world population with locally advanced #RectalCancer, #ctDNA had poor sensitivity and negative predictive value for residual disease post-total neoadjuvant therapy and should not be used alone to select patients for non-operative management. #crcsm https://lnkd.in/eXqhmfpY
Trastuzumab deruxtecan is an antibody-drug conjugate which has shown effectiveness in patients with HER2-low disease. In this MEDtalk Giuseppe Curigliano’s presents results from a phase three trial (DESTINY-Breast04) investigating the effectiveness and safety profile of trastuzumab deruxtecan which might should be considered in treatment algorithms for these patients. #HER2 #Phase3 #Treatment
Today marks World Kidney Cancer Day, and this year, the focus is on a powerful tool in fighting the disease: listening. But before we delve into that, let's talk about kidney cancer itself. Often called a "silent disease" because symptoms may not appear until later stages, being aware of the signs is crucial. Symptoms include : Blood in your urine, A persistent pain in your side or lower back, Anemia, Swollen ankles or legs: Fluid buildup in the extremities could indicate a kidney issue. Early detection is key! World Kidney Cancer Day is a chance to raise awareness and empower ourselves with knowledge. Share this post and educate others about the importance of listening to our bodies and advocating for open communication in healthcare. #Menagen #WorldKidneyCancerDay #KidneyCancer #SilentButSerious #KidneyHealth #ListenToYourBody #EarlyDetectionSavesLives #KidneyCancerSymptoms #KidneyCancerRisk
Do you have MGUS? Everyone should know the answer before they turn 60. MGUS is a precursor for developing multiple myeloma, a cancer of the blood which occurs In older adults. Because not everyone with MGUS goes on to develop multiple myeloma MGUS is not considered a disease. However if you know you have MGUS you can have a simple blood test biannually which allows for early detection and treatment to commence. Because testing for MGUS on otherwise healthy patients is not the norm in almost all cases the disease will not be detected until it is be well advanced. GET TESTED FOR MGUS BEFORE YOU TURN 60.
Founder & Client Services Director US - supporting the expansion of Biotech and Biopharma organisations
🌟 Exciting news alert! 🌟 The FDA has just given the green light to a groundbreaking point-of-care diagnostic test for hepatitis C. 🩺 Developed by Cepheid, this test can deliver results in just an hour using a simple fingerstick blood sample. 💉 The goal? To swiftly link patients with life-saving antiviral treatments and ramp up the diagnosis and treatment of hepatitis C. 🦠 With its high sensitivity, this test is a game-changer for active case detection and can be utilized across various healthcare settings. 🏥 The ultimate aim? To wipe out hepatitis C in the U.S. and slash liver cancer rates. 🚫🦠 Let's celebrate this major step forward in testing and prevention efforts for hepatitis C! 🎉 #HealthcareInnovation #HepatitisC #MedicalBreakthroughs
We support Rare Disease Day. George Clinical affirms its commitment to working with biotechs worldwide to advance breakthroughs in renal and cancer rare disease treatment. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #RareDiseaseDay2024
On World Sickle Cell Awareness Day, we're highlighting the crucial connection between sickle cell trait (SCT) and renal medullary carcinoma (RMC), a rare form of #kidneycancer. Early diagnosis and awareness are essential for managing and treating this disease. Join us in raising awareness and supporting research to improve diagnoses and outcomes. Learn more by visiting https://lnkd.in/eJSwqvvQ in partnership with Sickle Cell Disease Association of America, Inc. #SickleCellAwarenessDay #WorldSickleCellAwarenessDay #SickleCell #rmc #renalmedullarycarcinoma
A new report from US Pharmacopeia reveals that more than half of new #DrugShortages are #generic sterile injectables. Generic sterile injectables offer #patients lifesaving treatments that are both affordable and accessible for a variety of diseases, such as cancer, cardiovascular disease, and autoimmune disorders. Read the full report here: https://bit.ly/3yVinQI
Colorectal Cancer is the third most common cancer and the second leading cause of cancer-related death worldwide. So, why do so many people avoid the conversation when they're showing symptoms? Sure, it can be a little uncomfortable to discuss your bowel habits with anyone. However, no one should die because they're too embarrassed to talk about a potentially fatal medical condition, especially with their doctor. If you're experiencing symptoms such as a change in your bowel habits, persistent diarrhea or constipation, blood in your stool, rectal bleeding or abdominal pain, you should speak with your primary care provider right away. Additionally, if you're 45 or older, talk to your doctor about routine colorectal screening at your next appointment. In some cases, you may even need screening earlier or more often. Learn more about symptoms, screening guidelines and the resources we have at Tallahassee Memorial HealthCare(TMH) to fight this terrible disease at TMH.ORG/ColorectalCancer.
Today is #WorldLiverDay. We want to thank #WorldLiverDay for their continued efforts in shedding light on the rising burden of liver diseases and the urgent need for concerted global action. At Ascelia Pharma AB we strive to improve access to diagnosis of cancer in the liver for patients with severely impaired kidney function. #Stepupforliverhealth and #WorldLiverDay
